RANKL Inhibition Reduces Cardiac Hypertrophy in mdx Mice and Possibly in Children with Duchenne Muscular Dystrophy

Cardiomyopathy has become one of the leading causes of death in patients with Duchenne muscular dystrophy (DMD). We recently reported that the inhibition of the interaction between the receptor activator of nuclear factor κB ligand (RANKL) and receptor activator of nuclear factor κB (RANK) significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcadet, Laetitia, Juracic, Emma Sara, Khan, Nasrin, Bouredji, Zineb, Yagita, Hideo, Ward, Leanne M., Tupling, A. Russell, Argaw, Anteneh, Frenette, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253225/
https://www.ncbi.nlm.nih.gov/pubmed/37296659
http://dx.doi.org/10.3390/cells12111538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253225/
https://www.ncbi.nlm.nih.gov/pubmed/37296659
http://dx.doi.org/10.3390/cells12111538

Ejemplares similares